Search research articles
Contact Us
Filters
Showing results (641-650 of 750) with videos related to
Page
of 75
Sort By:
Journal of Neurodevelopmental Disorders
|
April 29, 2023
Rare recurrent copy number variations in metabotropic glutamate receptor interacting genes in children with neurodevelopmental disorders
Joseph T Glessner, Munir E Khan, Xiao Chang, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 15, 2015
Discovery of 2-(4-sulfonamidophenyl)-indole 3-carboxamides as potent and selective inhibitors with broad hepatitis C virus genotype activity targeting HCV NS4B
Nanjing Zhang, Anthony Turpoff, Xiaoyan Zhang, et al.
Brain : a Journal of Neurology
|
May 7, 2026
Targeting glutamatergic pathways: genetic insights into comorbid neurodevelopmental disorders
Joseph T Glessner, Munir E Khan, Xiao Chang, et al.
Journal of Medicinal Chemistry
|
March 23, 2010
Cyclic sulfones as novel P3-caps for hepatitis C virus NS3/4A (HCV NS3/4A) protease inhibitors: synthesis and evaluation of inhibitors with improved potency and pharmacokinetic profiles
Francisco Velázquez, Mousumi Sannigrahi, Frank Bennett, et al.
Journal of the American College of Cardiology
|
October 16, 2010
Sleep-disordered breathing, hypertension, and obesity in retired National Football League players
Felipe N Albuquerque, Fatima H Sert Kuniyoshi, Andrew D Calvin, et al.
Journal of Medicinal Chemistry
|
February 7, 2009
Second-generation highly potent and selective inhibitors of the hepatitis C virus NS3 serine protease
Kevin X Chen, Latha Nair, Bancha Vibulbhan, et al.
Journal of Medicinal Chemistry
|
April 18, 2009
Toward second generation hepatitis C virus NS3 serine protease inhibitors: discovery of novel P4 modified analogues with improved potency and pharmacokinetic profile
Ashok Arasappan, Angela I Padilla, Edwin Jao, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 24, 2015
6-(Azaindol-2-yl)pyridine-3-sulfonamides as potent and selective inhibitors targeting hepatitis C virus NS4B
Guangming Chen, Hongyu Ren, Nanjing Zhang, et al.
Antioxidants (Basel, Switzerland)
|
October 27, 2022
Identification of Cytoprotective Small-Molecule Inducers of Heme-Oxygenase-1
Gelare Ghajar-Rahimi, Amie M Traylor, Bini Mathew, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
March 2, 2006
Rejection with hemodynamic compromise: objective evidence for efficacy of photopheresis
J K Kirklin, R N Brown, S T Huang, et al.
Page
of 75
Search research articles
Search
Showing results (641-650 of 750) with videos related to
Sort By:
Page
of 75
Journal of Neurodevelopmental Disorders
|
April 29, 2023
Rare recurrent copy number variations in metabotropic glutamate receptor interacting genes in children with neurodevelopmental disorders
Joseph T Glessner, Munir E Khan, Xiao Chang, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 15, 2015
Discovery of 2-(4-sulfonamidophenyl)-indole 3-carboxamides as potent and selective inhibitors with broad hepatitis C virus genotype activity targeting HCV NS4B
Nanjing Zhang, Anthony Turpoff, Xiaoyan Zhang, et al.
Brain : a Journal of Neurology
|
May 7, 2026
Targeting glutamatergic pathways: genetic insights into comorbid neurodevelopmental disorders
Joseph T Glessner, Munir E Khan, Xiao Chang, et al.
Journal of Medicinal Chemistry
|
March 23, 2010
Cyclic sulfones as novel P3-caps for hepatitis C virus NS3/4A (HCV NS3/4A) protease inhibitors: synthesis and evaluation of inhibitors with improved potency and pharmacokinetic profiles
Francisco Velázquez, Mousumi Sannigrahi, Frank Bennett, et al.
Journal of the American College of Cardiology
|
October 16, 2010
Sleep-disordered breathing, hypertension, and obesity in retired National Football League players
Felipe N Albuquerque, Fatima H Sert Kuniyoshi, Andrew D Calvin, et al.
Journal of Medicinal Chemistry
|
February 7, 2009
Second-generation highly potent and selective inhibitors of the hepatitis C virus NS3 serine protease
Kevin X Chen, Latha Nair, Bancha Vibulbhan, et al.
Journal of Medicinal Chemistry
|
April 18, 2009
Toward second generation hepatitis C virus NS3 serine protease inhibitors: discovery of novel P4 modified analogues with improved potency and pharmacokinetic profile
Ashok Arasappan, Angela I Padilla, Edwin Jao, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 24, 2015
6-(Azaindol-2-yl)pyridine-3-sulfonamides as potent and selective inhibitors targeting hepatitis C virus NS4B
Guangming Chen, Hongyu Ren, Nanjing Zhang, et al.
Antioxidants (Basel, Switzerland)
|
October 27, 2022
Identification of Cytoprotective Small-Molecule Inducers of Heme-Oxygenase-1
Gelare Ghajar-Rahimi, Amie M Traylor, Bini Mathew, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
March 2, 2006
Rejection with hemodynamic compromise: objective evidence for efficacy of photopheresis
J K Kirklin, R N Brown, S T Huang, et al.
Page
of 75